Abstract
The report covers a forecast and an analysis of the immuno oncology assays market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the immuno oncology assays market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immuno oncology assays market on a global and regional level.
In order to give the users of this report a comprehensive view of the immuno oncology assays market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the immuno oncology assays market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the immuno oncology assays market on a global and regional basis.
The study provides a decisive view of the immuno oncology assays market by segmenting it based on product, assay, technology, indication, application, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some major players operating in the global immuno oncology assays market include Thermo Fisher Scientific, Agilent Technologies, Roche Diagnostics, Nanostring Technologies, Illumina, Foundation Medicine, Sartorius, Qiagen, HTG Molecular Diagnostics, PerkinElmer, and Merck.
This report segments the global immuno oncology assays market into:
Global Immuno Oncology Assays Market: By Product
Consumables
Software
Global Immuno Oncology Assays Market: By Assay
Cell Proliferation
Cell Migration and Invasion
Phagocytosis
Immune Cell Killing
Other
Global Immuno Oncology Assays Market: By Technology
PCR
Immunoassay
NGS
Flow Cytometry
Others
Global Immuno Oncology Assays Market: By Indication
Lung Cancer
Colorectal Cancer
Melanoma
Bladder Cancer
Other Cancers
Global Immuno Oncology Assays Market: By Application
Research Applications
Clinical Diagnostics
Global Immuno Oncology Assays Market: By Region
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa